Effect of a Strong Enzyme Inducer, Rifampin, on the Single-Dose Pharmacokinetics of Istradefylline in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 12 Mar 2016
At a glance
- Drugs Istradefylline (Primary) ; Rifampicin
- Indications Bacterial infections; Parkinson's disease
- Focus Pharmacokinetics
- Sponsors Kyowa Hakko Kirin
- 12 Mar 2016 Results presented at the 117th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.
- 02 Sep 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 28 Jun 2014 New trial record